Ultra-sensitive Biosensors for Clinical Diagnostics and Research
Graphene Frontiers, Pennsylvania, United States
Our innovation is a graphene biosensor that will revolutionize clinical diagnostics by shrinking lab-scale processes to automated chip-sized systems with unprecedented speed and sensitivity. The small size and sensitivity of the biosensor chips will enable multiplexing,testing for multiple biomarkers simultaneously, which will provide clinicians with comprehensive data for diagnosing patients.
Primary Application Area: Medical Devices
Technology Development Status: Prototype
Technology Readiness Level: TRL 3
FIGURES OF MERIT
Value Proposition: This IP is attractive to the market because the biosensors are highly sensitive, selective, allow multiplexing and testing for multiple biomarkers simultaneously, can be used at point of care and are cost effective. Highly sensitive and selective graphene-based biosensors will revolutionize point-of-care clinical diagnostics capabilities.
Organization Type: Early-stage Startup (Seed)
Showcase Booth #: 622
GOVT/EXTERNAL FUNDING SOURCES
Government Funding/Support to Date: Graphene Frontiers is proud to be supported by the National Science Foundation Awards:
Primary Sources of Funding: Angel, Friends, Family, Personal Savings, Federal Grant
Looking for: Both Funding and Development Partners